Bivalent enterovirus inactivated vaccine (Vero cells)(Sinovac Biotech)

二价肠道病毒灭活疫苗（Vero细胞）（北京科兴）

Report date: 2024/12/10 20:00:04

Base Information

Drug NameBivalent enterovirus inactivated vaccine (Vero cells)(Sinovac Biotech)
Drug Alias NameBivalent Enterovirus Vaccine (Vero Cell)inactivated bivalent Enterovirus type 71/Coxsackievirus A16 vaccine
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpanginaHand, Foot and Mouth DiseaseCoxsackievirus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSinovac Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsHerpanginaHand, Foot and Mouth DiseaseCoxsackievirus Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A